Alison J Cox Selected Research

Alison J Cox Research Topics

Disease

16	Diabetic Nephropathies (Diabetic Nephropathy) 01/2015 - 10/2001
12	Fibrosis (Cirrhosis) 02/2015 - 09/2003
8	Albuminuria 12/2013 - 08/2007
5	Hypertrophy 09/2013 - 08/2004
5	Proteinuria 01/2012 - 07/2002
5	Hypertension (High Blood Pressure) 08/2011 - 02/2005
3	Heart Failure 05/2012 - 08/2005
3	Diabetic Cardiomyopathies 05/2012 - 11/2007
2	Stroke (Strokes) 09/2013 - 03/2009
2	Glomerulonephritis 09/2011 - 06/2009
2	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2003 - 07/2002
1	Chronic Renal Insufficiency 01/2012
1	Atopic Dermatitis (Atopic Eczema) 12/2009
1	Asthma (Bronchial Asthma) 12/2009
1	Kidney Diseases (Kidney Disease) 06/2009
1	Diastolic Heart Failure 03/2009
1	Systolic Heart Failure 03/2009
1	Pathologic Neovascularization 09/2007
1	Neoplasms (Cancer) 09/2007
1	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2007
1	Myocardial Infarction 08/2005
1	Infarction (Infarctions) 08/2005
1	Skin Diseases (Skin Disease) 02/2005
1	Heart Diseases (Heart Disease) 02/2005
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2004
1	Nephrosis 01/2004
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 11/2003
1	Ischemia 05/2002
1	Hypoxia (Hypoxemia) 05/2002
1	Reperfusion Injury 05/2002

Drug/Important Bio-Agent (IBA)

6	CollagenIBA 01/2015 - 10/2001
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2012 - 10/2001
5	tranilastIBA 12/2013 - 02/2005
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2007 - 05/2002
4	Protein Kinase CIBA 09/2011 - 08/2005
4	Proteins (Proteins, Gene)FDA Link 01/2011 - 05/2002
4	ruboxistaurinIBA 06/2009 - 08/2005
4	Transforming Growth Factor beta (TGF-beta)IBA 03/2009 - 01/2002
3	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 01/2006
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015 - 04/2009
3	ThioredoxinsIBA 01/2015 - 04/2009
3	Messenger RNA (mRNA)IBA 09/2013 - 05/2002
3	FT011IBA 09/2013 - 01/2012
3	Streptozocin (Streptozotocin)FDA Link 01/2012 - 06/2002
3	Protein Isoforms (Isoforms)IBA 09/2011 - 08/2007
3	Protein Kinase C betaIBA 06/2009 - 08/2007
3	nephrinIBA 06/2009 - 07/2002
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2012 - 05/2002
2	EnzymesIBA 09/2011 - 06/2009
2	Angiotensin IIIBA 08/2011 - 01/2004
2	Epidermal Growth Factor (EGF)IBA 08/2011 - 01/2002
2	AntioxidantsIBA 01/2011 - 04/2009
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2007 - 05/2002
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2004 - 07/2002
2	pimagedine (aminoguanidine)IBA 07/2002 - 10/2001
1	Hydroxyproline (4 Hydroxyproline)IBA 02/2015
1	3-nitrotyrosineIBA 01/2015
1	Staphylococcal Protein A (Protein A)IBA 01/2015
1	Superoxides (Superoxide)IBA 01/2015
1	InflammasomesIBA 01/2015
1	Catalytic DNA (Deoxyribozyme)IBA 01/2015
1	3',4'- bis(difluoromethoxycinnamoylanthranilate)IBA 12/2013
1	Captopril (Capoten)FDA LinkGeneric 11/2012
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2012
1	Aligeron (AS 2)IBA 11/2012
1	Losartan (Cozaar)FDA LinkGeneric 11/2012
1	Collagen Type III (Type III Collagen)IBA 05/2012
1	C.I. direct red 80IBA 05/2012
1	Collagen Type I (Type I Collagen)IBA 05/2012
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2012
1	Platelet-Derived Growth FactorIBA 01/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2012
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2011
1	PKI 166IBA 08/2011
1	ErbB Receptors (EGF Receptor)IBA 08/2011
1	3-methoxy-4-propargyloxycinnamoyl anthranilateIBA 12/2009
1	ReninIBA 03/2009
1	AngiotensinsIBA 03/2009
1	AldosteroneIBA 03/2009
1	Adrenergic Agents (Adrenergic Drugs)IBA 03/2009
1	Phosphotransferases (Kinase)IBA 09/2007
1	anthranilic acid (anthranilate)IBA 02/2005
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2005
1	Imatinib Mesylate (Gleevec)FDA Link 08/2004
1	CreatinineIBA 01/2004
1	Puromycin AminonucleosideIBA 01/2004
1	SodiumIBA 01/2004
1	OsteopontinIBA 06/2002
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 05/2002
1	CytokinesIBA 10/2001
1	Advanced Glycation End ProductsIBA 10/2001

Therapy/Procedure

9	Therapeutics 02/2015 - 07/2002